Deletion of FABP4 increases PPARγ expression, and lipogenesis and insulin sensitivity in adipocytes (Garin-Shkolnik et al. 2014), suggesting that FABP4-dependent inhibition of PPARγ might favor insulin resistance and induction of inflammatory pathways associated with obesity. The gene discussed is FABP4; the disease is obesity disorder.